Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSORI-CM01 for Stable Plaque Psoriasis
NCT02153840Terminated
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Dec 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of PSORI-CM01 in plaque psoriasis (3 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Psoriasis Area and Severity Index 50% Reduction at 12 weeks. Started Dec 2013; status: terminated.
02
Drugs
PSORI-CM01
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02153840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153840.